Ouedrani, Amani
26  Ergebnisse:
Personensuche X
?
 
?
3

Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphoc..:

Delville, Marianne ; Touzot, Fabien ; Couzin, Chloé...
Molecular Therapy - Methods & Clinical Development.  13 (2019)  - p. 303-309 , 2019
 
?
5

Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifun..:

Serris, Alexandra ; Ouedrani, Amani ; Uhel, Fabrice...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.900522.  , 2022
 
?
6

Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifun..:

Serris, Alexandra ; Ouedrani, Amani ; Uhel, Fabrice...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.900522.  , 2022
 
?
7

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response again..:

Henriquez, Soledad ; Zerbit, Jérémie ; Bruel, Timothée...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood.2021013714.  , 2022
 
?
9

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response again..:

Henriquez, Soledad ; Zerbit, Jérémie ; Bruel, Timothée...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood.2021013714.  , 2022
 
?
10

Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifun..:

Serris, Alexandra ; Ouedrani, Amani ; Uhel, Fabrice...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.900522.  , 2022
 
?
11

Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifun..:

Serris, Alexandra ; Ouedrani, Amani ; Uhel, Fabrice...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.900522.  , 2022
 
?
12

Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifun..:

Serris, Alexandra ; Ouedrani, Amani ; Uhel, Fabrice...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.900522.  , 2022
 
?
14

Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifun..:

Serris, Alexandra ; Ouedrani, Amani ; Uhel, Fabrice...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2022.900522.  , 2022
 
?
15

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response again..:

Henriquez, Soledad ; Zerbit, Jérémie ; Bruel, Timothée...
info:eu-repo/semantics/altIdentifier/doi/10.1182/blood.2021013714.  , 2022
 
1-15